<DOC>
	<DOCNO>NCT01291134</DOCNO>
	<brief_summary>The purpose study evaluate rate quality spinal fusion utilize PureGen Osteoprogenitor Cell Allograft Anterior Cervical Discectomy Fusion ( ACDF ) .</brief_summary>
	<brief_title>PureGen : A Radiographic Analysis Rate Quality Fusion Patients Undergoing Anterior Cervical Discectomy Fusion ( ACDF )</brief_title>
	<detailed_description />
	<mesh_term>Intervertebral Disc Degeneration</mesh_term>
	<criteria>Persistent neck and/or arm pain consistent symptomatic cervical degenerative disc disease Moderate Neck Disability Index Unresponsive conservative treatment least 6 week More 4 level require surgical treatment Prior fail fusion surgery index level ( ) Systemic local infection disc cervical spine , past present Active systemic disease Osteoporosis , osteomalacia , metabolic bone disease would significantly inhibit bone heal Known suspected history alcohol and/or drug abuse Involved pending litigation worker 's compensation relate spine Pregnant plan become pregnant duration study Insulindependent diabetes mellitus Life expectancy less study duration Any significant psychological disturbance opinion Investigator could impair consent process ability complete selfassessment questionnaire BMI great 40 Undergoing chemotherapy radiation treatment , chronic use oral injected steroid prolong use nonsteroidal antiinflammatory drug Known history hypersensitivity anaphylactic reaction dimethyl sulfoxide ( DMSO ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
</DOC>